Growth Metrics

Fennec Pharmaceuticals (FENC) Cash & Current Investments (2010 - 2025)

Fennec Pharmaceuticals posted quarterly Cash & Current Investments of $36.8 million for Q4 2025, up 38.12% year-on-year from $26.6 million in Q4 2024, and up 67.62% on a QoQ basis from $21.9 million in Q3 2025.

Fennec Pharmaceuticals (FENC) has 16 years of Cash & Current Investments data on file, last reported at $36.8 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash & Current Investments rose 38.12% year-over-year to $36.8 million; the trailing twelve-month figure through Dec 2025 stood at $36.8 million (up 38.12% YoY), and the FY2025 full-year result was $36.8 million, up 38.12% from the prior year.
  • Cash & Current Investments for Q4 2025 stood at $36.8 million, up from $21.9 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $51.2 million in Q1 2024 and bottomed at $12.4 million in Q3 2023.
  • The 5-year median for Cash & Current Investments is $23.2 million (2022), against an average of $25.1 million.
  • The widest annual swing landed in 2023, when Cash & Current Investments tumbled 58.33%; it then soared 285.74% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $21.1 million in 2021, then climbed by 12.67% to $23.8 million in 2022, then sank by 44.19% to $13.3 million in 2023, then jumped by 100.72% to $26.6 million in 2024, then surged by 38.12% to $36.8 million in 2025.
  • The last three Cash & Current Investments figures came in at $36.8 million (Q4 2025), $21.9 million (Q3 2025), and $18.7 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.13 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 32.30 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 286.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 61.46 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 7.25 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 18.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 8.75 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.01 Bn
10 Fennec Pharmaceuticals 281.48 Mn 244.70 Mn 7.67 Mn 36.79 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 36.79 Mn
Sep 30, 2025 21.95 Mn
Jun 30, 2025 18.71 Mn
Mar 31, 2025 22.68 Mn
Dec 31, 2024 26.63 Mn
Sep 30, 2024 40.32 Mn
Jun 30, 2024 43.05 Mn
Mar 31, 2024 51.18 Mn
Dec 31, 2023 13.27 Mn
Sep 30, 2023 12.40 Mn
Jun 30, 2023 14.96 Mn
Mar 31, 2023 13.27 Mn
Dec 31, 2022 23.77 Mn
Sep 30, 2022 29.75 Mn
Jun 30, 2022 14.92 Mn
Mar 31, 2022 18.26 Mn
Dec 31, 2021 21.10 Mn
Sep 30, 2021 24.34 Mn
Jun 30, 2021 27.29 Mn
Mar 31, 2021 26.75 Mn
Dec 31, 2020 30.34 Mn
Sep 30, 2020 33.17 Mn
Jun 30, 2020 38.73 Mn
Mar 31, 2020 9.90 Mn
Dec 31, 2019 13.65 Mn
Sep 30, 2019 15.24 Mn
Jun 30, 2019 13.65 Mn
Mar 31, 2019 20.23 Mn
Dec 31, 2018 22.78 Mn
Sep 30, 2018 24.52 Mn
Jun 30, 2018 25.64 Mn
Mar 31, 2018 26.72 Mn
Dec 31, 2017 28.26 Mn
Sep 30, 2017 9.69 Mn
Jun 30, 2017 10.23 Mn
Mar 31, 2017 3.25 Mn
Dec 31, 2016 3.93 Mn
Sep 30, 2016 4.54 Mn
Jun 30, 2016 5.08 Mn
Mar 31, 2016 545,000.00
Dec 31, 2015 942,000.00
Sep 30, 2015 1.37 Mn
Jun 30, 2015 1.85 Mn
Mar 31, 2015 1.92 Mn
Dec 31, 2014 2.31 Mn
Sep 30, 2014 593,000.00
Jun 30, 2014 1.02 Mn
Mar 31, 2014 1.34 Mn
Dec 31, 2013 1.66 Mn
Sep 30, 2013 538,000.00
Jun 30, 2013 1.01 Mn
Mar 31, 2013 1.90 Mn
Dec 31, 2012 2.30 Mn
Sep 30, 2012 2.86 Mn
Jun 30, 2012 3.59 Mn
Mar 31, 2012 4.72 Mn
Dec 31, 2011 5.30 Mn
Sep 30, 2011 6.17 Mn
Jun 30, 2011 6.81 Mn
Mar 31, 2011 5.02 Mn
Dec 31, 2010 5.95 Mn
Sep 30, 2010 6.60 Mn
Jun 30, 2010 7.15 Mn